申请人:Bayer Aktiengesellschaft
公开号:US06476029B1
公开(公告)日:2002-11-05
The present invention relates to 7-alkyl- and cycloalkyl-substituted imidazotriazinones, to processes for their preparation and to their use as medicaments, in particular as inhibitors of cGMP-metabolizing phosphodiesterases.
本发明涉及7-烷基和环烷基取代的咪唑三嗪酮,其制备过程以及它们作为药物的用途,特别是作为cGMP代谢磷酸二酯酶的抑制剂。